South Africa Mrna Therapeutics Market Size & Outlook
South Africa mrna therapeutics market, 2021-2030 (US$M)
Related Markets
South Africa mrna therapeutics market highlights
- The South Africa mrna therapeutics market generated a revenue of USD 73.2 million in 2023 and is expected to reach USD 166.1 million by 2030.
- The South Africa market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating application in 2023.
- Infectious Diseases is the most lucrative application segment registering the fastest growth during the forecast period.
Mrna therapeutics market data book summary
| Market revenue in 2023 | USD 73.2 million |
| Market revenue in 2030 | USD 166.1 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Infectious Diseases |
| Historical data | 2021 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases |
| Key market players worldwide | Moderna Inc, BioNTech SE ADR, CureVac NV Ordinary Shares, Arcturus Therapeutics Holdings Inc, Sanofi SA, GSK PLC, Pfizer Inc, AstraZeneca PLC, Argos Therapeutics, ETHRIS |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global mrna therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia mrna therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 140.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Market Scope
MRNA Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa mrna therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the South Africa mrna therapeutics market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Many multinational companies, such as F. Hoffmann-La Roche Ltd., plan to focus on the South African market by forming joint ventures with local companies, such as Whitehead Scientific, for the raw materials required for mRNA synthesis in the country. Hence, several short-scale companies are setting up lab-scale mRNA vaccine manufacturing facilities to cater to the growing vaccine demand.
For instance, in January 2022, Afrigen Biologics, a biotechnology company based in Cape Town, produced an mRNA-based lab-scale batch of COVID-19 vaccine, fulfilling its commitment to WHO to establish an mRNA Technology Transfer Hub in South Africa.
This hub, a collaboration between the biotech company Afrigen, the South African Medical Research Council, and 14 other global partners, aims to develop mRNA vaccine production capabilities in low and middle-income countries.
Reasons to subscribe to South Africa mrna therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa mrna therapeutics market databook
-
Our clientele includes a mix of mrna therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa mrna therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa mrna therapeutics market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa mrna therapeutics market size, by application, 2021-2030 (US$M)
South Africa MRNA Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
